Literature DB >> 28923596

Chemically activated luminopsins allow optogenetic inhibition of distributed nodes in an epileptic network for non-invasive and multi-site suppression of seizure activity.

Jack K Tung1, Fu Hung Shiu2, Kevin Ding2, Robert E Gross3.   

Abstract

Although optogenetic techniques have proven to be invaluable for manipulating and understanding complex neural dynamics over the past decade, they still face practical and translational challenges in targeting networks involving multiple, large, or difficult-to-illuminate areas of the brain. We utilized inhibitory luminopsins to simultaneously inhibit the dentate gyrus and anterior nucleus of the thalamus of the rat brain in a hardware-independent and cell-type specific manner. This approach was more effective at suppressing behavioral seizures than inhibition of the individual structures in a rat model of epilepsy. In addition to elucidating mechanisms of seizure suppression never directly demonstrated before, this work also illustrates how precise multi-focal control of pathological circuits can be advantageous for the treatment and understanding of disorders involving broad neural circuits such as epilepsy.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Circuits; Epilepsy; Luminopsin; Networks; Optogenetics

Mesh:

Substances:

Year:  2017        PMID: 28923596      PMCID: PMC5696076          DOI: 10.1016/j.nbd.2017.09.007

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  41 in total

1.  In vivo evaluation of the dentate gate theory in epilepsy.

Authors:  Esther Krook-Magnuson; Caren Armstrong; Anh Bui; Sean Lew; Mikko Oijala; Ivan Soltesz
Journal:  J Physiol       Date:  2015-03-31       Impact factor: 5.182

2.  The effect of electrical stimulation and lesioning of the anterior thalamic nucleus on kainic acid-induced focal cortical seizure status in rats.

Authors:  Seiji Takebayashi; Kiyotaka Hashizume; Tatsuya Tanaka; Akira Hodozuka
Journal:  Epilepsia       Date:  2007-02       Impact factor: 5.864

3.  Bilateral anterior thalamic nucleus lesions and high-frequency stimulation are protective against pilocarpine-induced seizures and status epilepticus.

Authors:  Clement Hamani; Flavio I S Ewerton; Saulo M Bonilha; Gerson Ballester; Luiz E A M Mello; Andres M Lozano
Journal:  Neurosurgery       Date:  2004-01       Impact factor: 4.654

4.  Imaging the neural substrates involved in the genesis of pentylenetetrazol-induced seizures.

Authors:  Mathew E Brevard; Praveen Kulkarni; Jean A King; Craig F Ferris
Journal:  Epilepsia       Date:  2006-04       Impact factor: 5.864

5.  Pentylenetetrazol causes polysynaptic responses to appear in the dentate gyrus.

Authors:  J L Stringer
Journal:  Neuroscience       Date:  1995-09       Impact factor: 3.590

Review 6.  Optogenetic Approaches for Controlling Seizure Activity.

Authors:  Jack K Tung; Ken Berglund; Robert E Gross
Journal:  Brain Stimul       Date:  2016-07-14       Impact factor: 8.955

7.  Epileptic neuronal networks: methods of identification and clinical relevance.

Authors:  Hermann Stefan; Fernando H Lopes da Silva
Journal:  Front Neurol       Date:  2013-03-01       Impact factor: 4.003

Review 8.  Network Connectivity in Epilepsy: Resting State fMRI and EEG-fMRI Contributions.

Authors:  Maria Centeno; David W Carmichael
Journal:  Front Neurol       Date:  2014-07-04       Impact factor: 4.003

9.  Chemical-genetic attenuation of focal neocortical seizures.

Authors:  Dennis Kätzel; Elizabeth Nicholson; Stephanie Schorge; Matthew C Walker; Dimitri M Kullmann
Journal:  Nat Commun       Date:  2014-05-27       Impact factor: 14.919

10.  Multisite silicon neural probes with integrated silicon nitride waveguides and gratings for optogenetic applications.

Authors:  Euijae Shim; Yu Chen; Sotiris Masmanidis; Mo Li
Journal:  Sci Rep       Date:  2016-03-04       Impact factor: 4.379

View more
  11 in total

Review 1.  Optogenetics: the new molecular approach to control functions of neural cells in epilepsy, depression and tumors of the central nervous system.

Authors:  Bruno Camporeze; Bruno Alcântara Manica; Gabriel Alves Bonafé; Jivago Jordão Camargos Ferreira; Aurélio Lourenço Diniz; Carlos Tadeu Parisi de Oliveira; Luis Roberto Mathias Junior; Paulo Henrique Pires de Aguiar; Manoela Marques Ortega
Journal:  Am J Cancer Res       Date:  2018-10-01       Impact factor: 6.166

2.  Finding Your Inner Light: Using Bioluminescence to Control Seizures.

Authors:  Steve C Danzer
Journal:  Epilepsy Curr       Date:  2018 May-Jun       Impact factor: 7.500

3.  Bioluminescence-driven optogenetic activation of transplanted neural precursor cells improves motor deficits in a Parkinson's disease mouse model.

Authors:  Jessica R Zenchak; Brandon Palmateer; Nicolai Dorka; Tariq M Brown; Lina-Marie Wagner; William E Medendorp; Eric D Petersen; Mansi Prakash; Ute Hochgeschwender
Journal:  J Neurosci Res       Date:  2018-03-25       Impact factor: 4.164

Review 4.  New era of optogenetics: from the central to peripheral nervous system.

Authors:  Xiang Xu; Thomas Mee; Xiaofeng Jia
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-02-18       Impact factor: 8.250

Review 5.  Imaging biomarkers of epileptogenecity after traumatic brain injury - Preclinical frontiers.

Authors:  Riikka Immonen; Neil G Harris; David Wright; Leigh Johnston; Eppu Manninen; Gregory Smith; Afshin Paydar; Craig Branch; Olli Grohn
Journal:  Neurobiol Dis       Date:  2018-10-12       Impact factor: 5.996

6.  Applications of Bioluminescence-Optogenetics in Rodent Models.

Authors:  Matthew A Stern; Henry Skelton; Alejandra M Fernandez; Claire-Anne N Gutekunst; Robert E Gross; Ken Berglund
Journal:  Methods Mol Biol       Date:  2022

7.  Neurophotonic tools for microscopic measurements and manipulation: status report.

Authors:  Ahmed S Abdelfattah; Sapna Ahuja; Taner Akkin; Srinivasa Rao Allu; Joshua Brake; David A Boas; Erin M Buckley; Robert E Campbell; Anderson I Chen; Xiaojun Cheng; Tomáš Čižmár; Irene Costantini; Massimo De Vittorio; Anna Devor; Patrick R Doran; Mirna El Khatib; Valentina Emiliani; Natalie Fomin-Thunemann; Yeshaiahu Fainman; Tomas Fernandez-Alfonso; Christopher G L Ferri; Ariel Gilad; Xue Han; Andrew Harris; Elizabeth M C Hillman; Ute Hochgeschwender; Matthew G Holt; Na Ji; Kıvılcım Kılıç; Evelyn M R Lake; Lei Li; Tianqi Li; Philipp Mächler; Evan W Miller; Rickson C Mesquita; K M Naga Srinivas Nadella; U Valentin Nägerl; Yusuke Nasu; Axel Nimmerjahn; Petra Ondráčková; Francesco S Pavone; Citlali Perez Campos; Darcy S Peterka; Filippo Pisano; Ferruccio Pisanello; Francesca Puppo; Bernardo L Sabatini; Sanaz Sadegh; Sava Sakadzic; Shy Shoham; Sanaya N Shroff; R Angus Silver; Ruth R Sims; Spencer L Smith; Vivek J Srinivasan; Martin Thunemann; Lei Tian; Lin Tian; Thomas Troxler; Antoine Valera; Alipasha Vaziri; Sergei A Vinogradov; Flavia Vitale; Lihong V Wang; Hana Uhlířová; Chris Xu; Changhuei Yang; Mu-Han Yang; Gary Yellen; Ofer Yizhar; Yongxin Zhao
Journal:  Neurophotonics       Date:  2022-04-27       Impact factor: 4.212

8.  The BioLuminescent-OptoGenetic in vivo response to coelenterazine is proportional, sensitive, and specific in neocortex.

Authors:  Manuel Gomez-Ramirez; Alexander I More; Nina G Friedman; Ute Hochgeschwender; Christopher I Moore
Journal:  J Neurosci Res       Date:  2019-09-23       Impact factor: 4.164

9.  Predicting Successful Generation and Inhibition of Seizure-like Afterdischarges and Mapping Their Seizure Networks Using fMRI.

Authors:  Ben A Duffy; ManKin Choy; Jin Hyung Lee
Journal:  Cell Rep       Date:  2020-02-25       Impact factor: 9.423

Review 10.  Specificity, Versatility, and Continual Development: The Power of Optogenetics for Epilepsy Research.

Authors:  Zoé Christenson Wick; Esther Krook-Magnuson
Journal:  Front Cell Neurosci       Date:  2018-06-14       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.